Jan 24 (Reuters) - BIOCARTIS GROUP NV:
* BIOCARTIS & IMMUNEXPRESS SIGN PARTNERSHIP FOR A SEPSIS HOST IMMUNE RESPONSE TEST ON THE IDYLLA™ PLATFORM
* AGREEMENT TO DEVELOP, COMMERCIALIZE OF IMMUNEXPRESS’ SEPTICYPTE TEST FOR USE ON CO‘S SAMPLETO-RESULT IDYLLA PLATFORM‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)
 